{"id":"https://openalex.org/W7225081337","doi":"https://doi.org/10.1136/jsrd-2026-000052","title":"VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis","display_name":"VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis","publication_year":2026,"publication_date":"2026-07-01","ids":{"openalex":"https://openalex.org/W7225081337","doi":"https://doi.org/10.1136/jsrd-2026-000052","pmid":"https://pubmed.ncbi.nlm.nih.gov/42991098","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13735304"},"language":"en","primary_location":{"id":"doi:10.1136/jsrd-2026-000052","doi":"https://doi.org/10.1136/jsrd-2026-000052","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jsrd-2026-000052","pdf_url":"https://jsrd.bmj.com/content/jsrd/11/2/e000052.full.pdf","source":{"id":"https://openalex.org/S4210198508","display_name":"Journal of Scleroderma and Related Disorders","issn_l":"2397-1983","issn":["2397-1983","2397-1991"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Scleroderma and Related Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://jsrd.bmj.com/content/jsrd/11/2/e000052.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005002226","display_name":"Anna\u2010Maria Hoffmann\u2010Vold","orcid":"https://orcid.org/0000-0001-6467-7422","observed_orcids":["https://orcid.org/0000-0001-6467-7422"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH","NO"],"is_corresponding":true,"raw_author_name":"Anna-Maria Hoffmann-Vold","raw_affiliation_strings":["Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland","Oslo University Hospital, Oslo, Norway"],"raw_orcid":"https://orcid.org/0000-0001-6467-7422","affiliations":[{"raw_affiliation_string":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423","https://openalex.org/I4210100468"]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059359523","display_name":"Oliver Distler","orcid":"https://orcid.org/0000-0002-0546-8310","observed_orcids":["https://orcid.org/0000-0002-0546-8310","https://orcid.org/0000-0002-2413-1959"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Oliver Distler","raw_affiliation_strings":["Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-0546-8310","affiliations":[{"raw_affiliation_string":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048430823","display_name":"Yannick Allanore","orcid":"https://orcid.org/0000-0002-6149-0002","observed_orcids":["https://orcid.org/0000-0002-6149-0002"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yannick Allanore","raw_affiliation_strings":["Rheumatology Department, Saint Joseph Hospital, Universit\u00e9 Paris Cit\u00e9, INSERM U1016, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Department, Saint Joseph Hospital, Universit\u00e9 Paris Cit\u00e9, INSERM U1016, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061710037","display_name":"Francesco Del Galdo","orcid":"https://orcid.org/0000-0002-8528-2283","observed_orcids":["https://orcid.org/0000-0002-8528-2283","https://orcid.org/0000-0002-7694-9509"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Francesco Del Galdo","raw_affiliation_strings":["NIHR Biomedical Research Centre and Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIHR Biomedical Research Centre and Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105923117","display_name":"Christopher Paul Denton","orcid":"https://orcid.org/0000-0003-3975-8938","observed_orcids":["https://orcid.org/0000-0003-3975-8938","https://orcid.org/0000-0003-3070-1775"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher P Denton","raw_affiliation_strings":["UCL Medical School, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCL Medical School, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075788011","display_name":"Masataka Kuwana","orcid":"https://orcid.org/0000-0001-8352-6136","observed_orcids":["https://orcid.org/0000-0001-8352-6136"]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masataka Kuwana","raw_affiliation_strings":["Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073269240","display_name":"Dinesh Khanna","orcid":"https://orcid.org/0000-0003-1412-4453","observed_orcids":["https://orcid.org/0000-0003-1412-4453"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dinesh Khanna","raw_affiliation_strings":["University of Michigan, Ann Arbor, Michigan, USA"],"raw_orcid":"https://orcid.org/0000-0003-1412-4453","affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, Michigan, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040906895","display_name":"Zsuzsanna Hortobagyi McMahan","orcid":"https://orcid.org/0000-0001-6461-8940","observed_orcids":["https://orcid.org/0000-0001-6461-8940"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zsuzsanna H McMahan","raw_affiliation_strings":["UTHealth Houston, Houston, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0001-6461-8940","affiliations":[{"raw_affiliation_string":"UTHealth Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018731653","display_name":"Elizabeth R. Volkmann","orcid":"https://orcid.org/0000-0003-3750-6569","observed_orcids":["https://orcid.org/0000-0003-3750-6569"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth R Volkmann","raw_affiliation_strings":["University of California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159854196","display_name":"Hao Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hao Li","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041976718","display_name":"Mihaela Dumistracel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Mihaela Dumistracel","raw_affiliation_strings":["Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112539018","display_name":"Martina Gahlemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123729","display_name":"Boehringer Ingelheim (Switzerland)","ror":"https://ror.org/02rtpt551","country_code":"CH","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210123729"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martina Gahlemann","raw_affiliation_strings":["Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland","institution_ids":["https://openalex.org/I4210123729"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091576695","display_name":"Susanne Stowasser","orcid":"https://orcid.org/0009-0008-6013-0225","observed_orcids":["https://orcid.org/0009-0008-6013-0225"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Susanne Stowasser","raw_affiliation_strings":["Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024950256","display_name":"Shervin Assassi","orcid":"https://orcid.org/0000-0002-8059-9978","observed_orcids":["https://orcid.org/0000-0002-8059-9978"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shervin Assassi","raw_affiliation_strings":["UTHealth Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UTHealth Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5005002226"],"corresponding_institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I202697423","https://openalex.org/I4210100468"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":{"value":4150,"currency":"USD","value_usd":4150},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8463265,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"2","first_page":"e000052","last_page":"e000052"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13313","display_name":"Dupuytren's Contracture and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/nerandomilast","display_name":"nerandomilast","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.8050000071525574},{"id":"https://openalex.org/keywords/skin-thickness","display_name":"skin thickness","score":0.5389999747276306},{"id":"https://openalex.org/keywords/forced-vital-capacity","display_name":"forced vital capacity","score":0.7319999933242798},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7639999985694885},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.6850000023841858},{"id":"https://openalex.org/keywords/vascular-protection","display_name":"vascular protection","score":0.9649999737739563},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cyp3a-inhibitors","display_name":"CYP3A inhibitors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6850000023841858},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9117000102996826},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7142999768257141},{"id":"https://openalex.org/C2910384678","wikidata":"https://www.wikidata.org/wiki/Q6744211","display_name":"Mallinckrodt","level":2,"score":0.6521999835968018},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6435999870300293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6128000020980835},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5810999870300293},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.5031999945640564},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5027999877929688},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.49470001459121704},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.48980000615119934},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.4657000005245209},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.4077000021934509},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.4025000035762787},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.3619999885559082},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.3483000099658966},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34630000591278076},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.3400000035762787},{"id":"https://openalex.org/C2779967694","wikidata":"https://www.wikidata.org/wiki/Q1383511","display_name":"Scleroderma (fungus)","level":3,"score":0.33180001378059387},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3231000006198883},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2948000133037567},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.29109999537467957},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.2808000147342682},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.273499995470047},{"id":"https://openalex.org/C2778674544","wikidata":"https://www.wikidata.org/wiki/Q1414805","display_name":"Systemic disease","level":3,"score":0.26930001378059387},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.26030001044273376},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2531999945640564},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25209999084472656}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1136/jsrd-2026-000052","doi":"https://doi.org/10.1136/jsrd-2026-000052","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jsrd-2026-000052","pdf_url":"https://jsrd.bmj.com/content/jsrd/11/2/e000052.full.pdf","source":{"id":"https://openalex.org/S4210198508","display_name":"Journal of Scleroderma and Related Disorders","issn_l":"2397-1983","issn":["2397-1983","2397-1991"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Scleroderma and Related Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13735304","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735304/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735304/pdf/jsrd-11-2.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Scleroderma Relat Disord","raw_type":"Text"},{"id":"pmid:42991098","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42991098","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of scleroderma and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1136/jsrd-2026-000052","doi":"https://doi.org/10.1136/jsrd-2026-000052","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jsrd-2026-000052","pdf_url":"https://jsrd.bmj.com/content/jsrd/11/2/e000052.full.pdf","source":{"id":"https://openalex.org/S4210198508","display_name":"Journal of Scleroderma and Related Disorders","issn_l":"2397-1983","issn":["2397-1983","2397-1991"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Scleroderma and Related Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310420","display_name":"CSL Behring","ror":"https://ror.org/01jxhxv92"},{"id":"https://openalex.org/F4320315424","display_name":"aTyr","ror":"https://ror.org/05edt5833"},{"id":"https://openalex.org/F4320316495","display_name":"Kissei","ror":"https://ror.org/028gkfr23"},{"id":"https://openalex.org/F4320318412","display_name":"Argenx","ror":"https://ror.org/04spfxf63"},{"id":"https://openalex.org/F4320325987","display_name":"Galderma","ror":"https://ror.org/05fswdm20"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225081337.pdf","grobid_xml":"https://content.openalex.org/works/W7225081337.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W2017472623","https://openalex.org/W2312027770","https://openalex.org/W2347093301","https://openalex.org/W2508060872","https://openalex.org/W2589893823","https://openalex.org/W2803995891","https://openalex.org/W2910001595","https://openalex.org/W2945521814","https://openalex.org/W3007003780","https://openalex.org/W3012133867","https://openalex.org/W3081624185","https://openalex.org/W3108496306","https://openalex.org/W3118532049","https://openalex.org/W3137028214","https://openalex.org/W3215468816","https://openalex.org/W4214622229","https://openalex.org/W4283694405","https://openalex.org/W4286001097","https://openalex.org/W4310080081","https://openalex.org/W4387772617","https://openalex.org/W4400422023","https://openalex.org/W4403331150","https://openalex.org/W4403627832","https://openalex.org/W4404059685","https://openalex.org/W4404828011","https://openalex.org/W4409486987","https://openalex.org/W4409899728","https://openalex.org/W4410202676","https://openalex.org/W4410352771","https://openalex.org/W4410472815","https://openalex.org/W4410493785","https://openalex.org/W4411411786","https://openalex.org/W4413343125","https://openalex.org/W4413992417","https://openalex.org/W4414060095","https://openalex.org/W7130308172","https://openalex.org/W7130829221","https://openalex.org/W7140815262","https://openalex.org/W7163695985","https://openalex.org/W7168355487"],"related_works":["https://openalex.org/W7163695985","https://openalex.org/W7163658460","https://openalex.org/W7215832361","https://openalex.org/W4409899728","https://openalex.org/W7167803614","https://openalex.org/W6967299972","https://openalex.org/W2889967772","https://openalex.org/W2907506804","https://openalex.org/W4224011248","https://openalex.org/W3155994784"],"abstract_inverted_index":{"Introduction:":[0],"Systemic":[1],"sclerosis":[2],"(SSc)":[3],"is":[4,166,215,219],"a":[5,12,46,114,133,220],"rare,":[6],"heterogeneous,":[7],"autoimmune":[8],"disease.":[9],"It":[10],"involves":[11],"complex":[13],"interplay":[14],"of":[15,75,162,175,178,200,222,228],"immune":[16],"dysregulation,":[17],"vasculopathy":[18],"and":[19,33,55,73,82,157,190,282],"fibrosis.":[20],"There":[21],"are":[22],"no":[23],"widely":[24],"approved":[25],"drugs":[26],"that":[27],"target":[28],"all":[29],"three":[30],"underlying":[31],"mechanisms":[32],"modify":[34],"the":[35,71,159,171,198,225],"overall":[36,42],"SSc":[37,102],"disease":[38,43,185,193,233,253],"course":[39],"or":[40,116,135,141,205,212,235,237,256,275],"prevent":[41],"progression.":[44],"Nerandomilast,":[45],"preferential":[47],"phosphodiesterase":[48],"4B":[49],"inhibitor,":[50],"has":[51],"demonstrated":[52],"antifibrotic,":[53],"immunomodulatory":[54],"vasculoprotective":[56],"effects":[57],"in":[58,77,118,241,259,271],"models":[59],"relevant":[60],"to":[61,107,120,128,224],"SSc.":[62,80],"The":[63,123],"phase":[64],"III":[65],"VERANDA-SSc":[66],"trial":[67,88],"(NCT07497087)":[68],"will":[69,89,103,150,285],"investigate":[70],"efficacy":[72],"safety":[74],"nerandomilast":[76,111],"patients":[78,100,168,201,249],"with":[79,101,145,202,250,267],"Methods":[81],"analysis:":[83],"This":[84],"double-blind,":[85],"randomised,":[86],"placebo-controlled":[87],"be":[90,104,126,287],"conducted":[91],"at":[92,153,254],"~235":[93],"sites":[94],"across":[95],"45":[96],"countries.":[97],"Approximately":[98],"450":[99],"randomised":[105],"1:1":[106],"receive":[108],"18":[109],"mg":[110,130],"two":[112,131],"times":[113,132],"day":[115,134],"placebo":[117],"addition":[119],"standard-of-care":[121],"therapy.":[122],"dose":[124],"may":[125],"reduced":[127],"9":[129],"interrupted":[136],"based":[137],"on":[138],"individual":[139],"tolerability":[140],"if":[142],"used":[143],"concomitantly":[144],"strong":[146],"CYP3A":[147],"inhibitors.":[148],"Treatment":[149],"continue":[151],"for":[152,180],"least":[154],"52":[155],"weeks":[156],"until":[158],"planned":[160],"number":[161],"primary":[163,217],"endpoint":[164,218],"events":[165],"reached.Adult":[167],"must":[169],"meet":[170],"2013":[172],"American":[173],"College":[174],"Rheumatology/European":[176],"Alliance":[177],"Associations":[179],"Rheumatology":[181],"classification":[182],"criteria,":[183],"have":[184,191],"onset":[186],"within":[187],"7":[188],"years":[189],"active":[192],"(key":[194],"inclusion":[195],"criteria":[196],"permit":[197],"enrolment":[199],"diffuse":[203],"cutaneous":[204,207],"limited":[206],"SSc).":[208],"Stable":[209],"background":[210],"immunosuppressive":[211],"nintedanib":[213],"therapy":[214],"allowed.The":[216],"composite":[221],"time":[223],"first":[226],"occurrence":[227],"predefined":[229],"SSc-related":[230],"clinically":[231],"meaningful":[232],"progression":[234],"complications,":[236],"confirmed":[238],"absolute":[239,269],"decline":[240],"forced":[242],"vital":[243],"capacity":[244],"%":[245],"predicted":[246],"\u22655%":[247],"(for":[248],"interstitial":[251],"lung":[252],"baseline),":[255],"relative":[257],"increase":[258,270],"modified":[260],"Rodnan":[261],"skin":[262],"score":[263],"(mRSS)":[264],"\u226525%":[265],"together":[266],"an":[268],"mRSS":[272],"\u22655":[273],"points,":[274],"all-cause":[276],"death.":[277],"Safety,":[278],"pharmacokinetics,":[279],"organ":[280],"manifestations":[281],"patient-reported":[283],"outcomes":[284],"also":[286],"assessed.":[288],"Trial":[289],"registration":[290],"number:":[291],"NCT07497087.":[292]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-03T00:00:00"}